139 related articles for article (PubMed ID: 10670451)
1. Selective neuroprotective effects with insulin-like growth factor-1 in phenotypic striatal neurons following ischemic brain injury in fetal sheep.
Guan J; Bennet TL; George S; Waldvogel HJ; Faull RL; Gluckman PD; Keunen H; Gunn AJ
Neuroscience; 2000; 95(3):831-9. PubMed ID: 10670451
[TBL] [Abstract][Full Text] [Related]
2. Induced cerebral hypothermia reduces post-hypoxic loss of phenotypic striatal neurons in preterm fetal sheep.
George S; Scotter J; Dean JM; Bennet L; Waldvogel HJ; Guan J; Faull RL; Gunn AJ
Exp Neurol; 2007 Jan; 203(1):137-47. PubMed ID: 16962098
[TBL] [Abstract][Full Text] [Related]
3. The effects of the N-terminal tripeptide of insulin-like growth factor-1, glycine-proline-glutamate in different regions following hypoxic-ischemic brain injury in adult rats.
Guan J; Waldvogel HJ; Faull RL; Gluckman PD; Williams CE
Neuroscience; 1999 Mar; 89(3):649-59. PubMed ID: 10199602
[TBL] [Abstract][Full Text] [Related]
4. Administration of recombinant human Activin-A has powerful neurotrophic effects on select striatal phenotypes in the quinolinic acid lesion model of Huntington's disease.
Hughes PE; Alexi T; Williams CE; Clark RG; Gluckman PD
Neuroscience; 1999; 92(1):197-209. PubMed ID: 10392842
[TBL] [Abstract][Full Text] [Related]
5. nNOS inhibition during profound asphyxia reduces seizure burden and improves survival of striatal phenotypic neurons in preterm fetal sheep.
Drury PP; Davidson JO; Mathai S; van den Heuij LG; Ji H; Bennet L; Tan S; Silverman RB; Gunn AJ
Neuropharmacology; 2014 Aug; 83():62-70. PubMed ID: 24726307
[TBL] [Abstract][Full Text] [Related]
6. AAV-mediated gene delivery of BDNF or GDNF is neuroprotective in a model of Huntington disease.
Kells AP; Fong DM; Dragunow M; During MJ; Young D; Connor B
Mol Ther; 2004 May; 9(5):682-8. PubMed ID: 15120329
[TBL] [Abstract][Full Text] [Related]
7. The IGF-I amino-terminal tripeptide glycine-proline-glutamate (GPE) is neuroprotective to striatum in the quinolinic acid lesion animal model of Huntington's disease.
Alexi T; Hughes PE; van Roon-Mom WM; Faull RL; Williams CE; Clark RG; Gluckman PD
Exp Neurol; 1999 Sep; 159(1):84-97. PubMed ID: 10486177
[TBL] [Abstract][Full Text] [Related]
8. Repeated asphyxia causes loss of striatal projection neurons in the fetal sheep brain.
Mallard EC; Waldvogel HJ; Williams CE; Faull RL; Gluckman PD
Neuroscience; 1995 Apr; 65(3):827-36. PubMed ID: 7609881
[TBL] [Abstract][Full Text] [Related]
9. Intranuclear inclusions in subtypes of striatal neurons in Huntington's disease transgenic mice.
Kosinski CM; Cha JH; Young AB; Mangiarini L; Bates G; Schiefer J; Schwarz M
Neuroreport; 1999 Dec; 10(18):3891-6. PubMed ID: 10716229
[TBL] [Abstract][Full Text] [Related]
10. Protective effects of neurotrophin-4/5 and transforming growth factor-alpha on striatal neuronal phenotypic degeneration after excitotoxic lesioning with quinolinic acid.
Alexi T; Venero JL; Hefti F
Neuroscience; 1997 May; 78(1):73-86. PubMed ID: 9135090
[TBL] [Abstract][Full Text] [Related]
11. Relative resistance of striatal neurons containing calbindin or parvalbumin to quinolinic acid-mediated excitotoxicity compared to other striatal neuron types.
Figueredo-Cardenas G; Harris CL; Anderson KD; Reiner A
Exp Neurol; 1998 Feb; 149(2):356-72. PubMed ID: 9500958
[TBL] [Abstract][Full Text] [Related]
12. Time dependent changes of striatal interneurons after focal cerebral ischemia in rats.
Sakuma M; Hyakawa N; Kato H; Araki T
J Neural Transm (Vienna); 2008; 115(3):413-22. PubMed ID: 18301954
[TBL] [Abstract][Full Text] [Related]
13. alpha-actinin-2 in rat striatum: localization and interaction with NMDA glutamate receptor subunits.
Dunah AW; Wyszynski M; Martin DM; Sheng M; Standaert DG
Brain Res Mol Brain Res; 2000 Jun; 79(1-2):77-87. PubMed ID: 10925145
[TBL] [Abstract][Full Text] [Related]
14. Density and neurochemical profiles of neuronal nitric oxide synthase-expressing interneuron in the mouse basolateral amygdala.
Wang X; Liu C; Wang X; Gao F; Zhan RZ
Brain Res; 2017 May; 1663():106-113. PubMed ID: 28213154
[TBL] [Abstract][Full Text] [Related]
15. D1 dopamine receptor agonist-induced Fos-like immunoreactivity occurs in basal forebrain and mesopontine tegmentum cholinergic neurons and striatal neurons immunoreactive for neuropeptide Y.
Robertson GS; Staines WA
Neuroscience; 1994 Mar; 59(2):375-87. PubMed ID: 7911982
[TBL] [Abstract][Full Text] [Related]
16. Stereological assessment of vulnerability of immunocytochemically identified striatal and hippocampal neurons after global cerebral ischemia in rats.
Larsson E; Lindvall O; Kokaia Z
Brain Res; 2001 Sep; 913(2):117-32. PubMed ID: 11549375
[TBL] [Abstract][Full Text] [Related]
17. Selective neuronal vulnerability following mild focal brain ischemia in the mouse.
Katchanov J; Waeber C; Gertz K; Gietz A; Winter B; Brück W; Dirnagl U; Veh RW; Endres M
Brain Pathol; 2003 Oct; 13(4):452-64. PubMed ID: 14655751
[TBL] [Abstract][Full Text] [Related]
18. Molecular phenotype of rat striatal neurons expressing the dopamine D5 receptor subtype.
Rivera A; Alberti I; Martín AB; Narváez JA; de la Calle A; Moratalla R
Eur J Neurosci; 2002 Dec; 16(11):2049-58. PubMed ID: 12473072
[TBL] [Abstract][Full Text] [Related]
19. A group of cortical interneurons expressing mu-opioid receptor-like immunoreactivity: a double immunofluorescence study in the rat cerebral cortex.
Taki K; Kaneko T; Mizuno N
Neuroscience; 2000; 98(2):221-31. PubMed ID: 10854753
[TBL] [Abstract][Full Text] [Related]
20. Neurturin protects striatal projection neurons but not interneurons in a rat model of Huntington's disease.
Pérez-Navarro E; Akerud P; Marco S; Canals JM; Tolosa E; Arenas E; Alberch J
Neuroscience; 2000; 98(1):89-96. PubMed ID: 10858615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
